Xvivo Perfusion Dividends and Buybacks
Dividend criteria checks 0/6
Xvivo Perfusion does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-3.0%
Buyback Yield
| Total Shareholder Yield | -3.0% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Xvivo Perfusion (STO:XVIVO) Is Posting Healthy Earnings, But It Is Not All Good News
Nov 04
Results: Xvivo Perfusion AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 27With Xvivo Perfusion AB (publ) (STO:XVIVO) It Looks Like You'll Get What You Pay For
Oct 25Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 40% Undervaluation?
Aug 03Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Apr 25There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital
Apr 11Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates
Feb 05We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings
Feb 01Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jan 28Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled
Aug 24Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching
Jul 17Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?
Jun 16Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital
Apr 19Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?
Mar 23With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case
Mar 07When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?
Feb 13Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Dec 14Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?
Nov 17Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively
Aug 20Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are
Jul 21Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital
Mar 30At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?
Feb 18A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)
Jan 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if XVIVO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if XVIVO's dividend payments have been increasing.
Dividend Yield vs Market
| Xvivo Perfusion Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (XVIVO) | n/a |
| Market Bottom 25% (SE) | 1.6% |
| Market Top 25% (SE) | 4.8% |
| Industry Average (Medical Equipment) | 1.6% |
| Analyst forecast (XVIVO) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate XVIVO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate XVIVO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate XVIVO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as XVIVO has not reported any payouts.